Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer – a dose-finding study by the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Ovarian Cancer Study Group

Authors:
  • HLH. J. Lück
    H. J. Lück
  • WSW. Schroeder
    W. Schroeder
  • JBJ. U. Blohmer
    J. U. Blohmer
  • VMV. Moebus
    V. Moebus

Abstract
No abstract available

This publication has 24 references indexed in Scilit: